EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Routine brain MRI in suspected lung cancer: clinical justification and diagnostic yield

Camilla Hviid, Christian B Laursen, Pia Iben Pietersen, Anne Lerberg Nielsen, Lotte Holm Land, Anja Gouliaev, Arman Arshad, Uffe Bodtger, Amanda Dandanell Jull

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2025.101083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Camilla Hviid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark; Odense Respiratory Research Unit (ODIN), Department of Clinical Rese…. Hauptthemen laut MEDLINE: Lung Neoplasms, Magnetic Resonance Imaging, Brain Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Brain metastases are common and associated with poor prognosis. While MRI is highly sensitive for detecting brain metastases, the clinical value of routinely adding up-front MRI to PET/CT during initial staging remains debated. This study focuses on suspected lung cancer patients, integrating workflow data (MRI waiting time, MDT availability) to evaluate up-front brain MRI and its impact on clinical decision-making. METHODS: This retrospective cohort study included 183 patients with suspected lung cancer referred for up-front brain MRI at Odense University Hospital between March-August 2021. All patients underwent pre-diagnostic PET/CT, and brain MRI was performed in cases with suspected stage II-IV disease (TNM 8th edition). RESULTS: Brain metastases were detected by MRI in 21/183 patients (11.5%), predominantly from primary lung cancer (n = 19, 90.4%). Among patients with confirmed lung cancer (n = 134), the prevalence was 14.2% (19/134), corresponding to a number needed to scan (NNS) of 7.1; across the full cohort, the NNS was 8.7. MRI led to upstaging to stage IV disease in 3/134 lung cancer patients (2.2%), resulting in a NNS of 44.7. PET/CT had a positive predictive value of 57.1% and a negative predictive value of 90.3%, indicating limited reliability detecting brain metastases. CONCLUSION: Routine up-front brain MRI identified brain metastases in a small but clinically relevant subset of patients, primarily those with signs of dissemination on initial PET/CT. A risk-stratified approach targeting high-risk groups may reduce MRI use without compromising detection, improving staging efficiency and resource allocation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMagnetic Resonance ImagingBrain NeoplasmsHumansFemaleRetrospective StudiesMaleAgedMiddle AgedPositron Emission Tomography Computed TomographyNeoplasm StagingAged, 80 and overAdult

Stichwörter der Autor:innen

Lung cancer, Brain metastasesMRINon-small cell lung cancerSmall cell lung cancerStaging

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Electronic addr…
  • Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Radiology, Odense University Hospital, Odense, Denmark; Research and Innovation Unit of Radiology (UNIFY), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark; Research unit of Clinical Physiology and Nuclear Medicine, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Oncology, Odense University Hospital, Odense, Denmark; Research Unit of Oncology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Respiratory Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine - Lung Diseases, Aarhus University, Aarhus, Denmark.

Zitieren

APA

Hviid, C., Laursen, C. B., Pietersen, P. I., Nielsen, A. L., Land, L. H., Gouliaev, A., Arshad, A., Bodtger, U., & Jull, A. D. (2026). Routine brain MRI in suspected lung cancer: clinical justification and diagnostic yield. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101083

Vancouver

Hviid C, Laursen CB, Pietersen PI, Nielsen AL, Land LH, Gouliaev A, et al. Routine brain MRI in suspected lung cancer: clinical justification and diagnostic yield. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2025.101083

BibTeX
@article{Hviid2026,
  author = {Hviid, Camilla and Laursen, Christian B and Pietersen, Pia Iben and Nielsen, Anne Lerberg and Land, Lotte Holm and Gouliaev, Anja and Arshad, Arman and Bodtger, Uffe and Jull, Amanda Dandanell},
  title = {Routine brain MRI in suspected lung cancer: clinical justification and diagnostic yield},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2025.101083}
}
Kostenlos starten →